1)National Institute for Health and Care Excellence(NICE):Alcohol-use disorders:diagnosis, assessment and management of harmful drinking and alcohol dependence. Clinical guideline[CG115]. 2011 https://www.nice.org.uk/guidance/cg115/(2020年2月20日閲覧)
2)新アルコール・薬物使用障害の診断治療ガイドライン作成委員会監修:新アルコール・薬物使用障害の診断治療ガイドライン.新興医学出版社,2018
3)National Treatment Agency for Substance Misuse:Review of the effectiveness of treatment for alcohol problems. 2006 http://www.dldocs.stir.ac.uk/documents/alcoeffective.pdf(2020年2月20日閲覧)
4)Osaki Y, Kinjo A, Higuchi S, et al:Prevalence and trends in alcohol dependence and alcohol use disorders in Japanese Adults:results from periodical nationwide surveys. Alcohol Alcohol 51:465-473, 2016
5)National Institute for Health and Care Excellence(NICE):Nalmefene for reducing alcohol consumption in people with alcohol dependence. 2014 https://www.nice.org.uk/guidance/ta325(2020年2月20日閲覧)
6)International Harm Reduction Association:What is Harm Reduction? 2010 https://www.hri.global/files/2010/05/31/IHRA_HRStatement.pdf(2020年2月20日閲覧)
7)Harm Reduction International:What is harm reduction? 2019 https://www.hri.global/what-is-harm-reduction(2020年2月20日閲覧)